Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Airborne Infectious Microorganisms

Identifieur interne : 000962 ( Pmc/Corpus ); précédent : 000961; suivant : 000963

Airborne Infectious Microorganisms

Auteurs : L. D. Stetzenbach

Source :

RBID : PMC:7150350

Abstract

Inhalation exposes the upper and lower respiratory tracts of humans to a variety of airborne particles and vapors. Airborne transmission of pathogenic microorganisms to humans from the environment, animals, or other humans can result in disease. Inhalation is an important route of exposure as the lung is more susceptible to infection than the gastrointestinal tract. Ingested microorganisms must past through the acidic environment of the stomach before they can colonize tissue while inhaled microorganisms are deposited directly on the moist surfaces of the respiratory tract. Inhalation of microbial aerosols can elicit adverse human health effects including infection, allergic reaction, inflammation, and respiratory disease. Following inhalation, infectious viruses, bacteria, and fungi can establish in host cells of the respiratory tract. Some are translocated and infect the gastrointestinal tract and other tissues. This chapter discusses human viral, bacterial, and fungal diseases transmitted via aerosols. Viral diseases presented are influenza, severe acute respiratory syndrome (SARS), Norwalk-like viruses (NLVs) and hantavirus disease, measles, and varicella. Bacterial diseases are Legionnaires’ disease, tuberculosis, and nontubercule mycobacterial disease. Exposure to some Gram-negative and Gram-positive bacteria, endotoxin, and actinomycetes when dispersed through the air can result in disease following inhalation. Fungal diseases included are histoplasmosis, coccidiomycosis, blastomycosis, cryptococcosis, and aspergillosis. The threat of bioterrorism with airborne infectious agents is also briefly presented.


Url:
DOI: 10.1016/B978-012373944-5.00177-2
PubMed: NONE
PubMed Central: 7150350

Links to Exploration step

PMC:7150350

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Airborne Infectious Microorganisms</title>
<author>
<name sortKey="Stetzenbach, L D" sort="Stetzenbach, L D" uniqKey="Stetzenbach L" first="L. D." last="Stetzenbach">L. D. Stetzenbach</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmc">7150350</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150350</idno>
<idno type="RBID">PMC:7150350</idno>
<idno type="doi">10.1016/B978-012373944-5.00177-2</idno>
<idno type="pmid">NONE</idno>
<date when="2009">2009</date>
<idno type="wicri:Area/Pmc/Corpus">000962</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000962</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Airborne Infectious Microorganisms</title>
<author>
<name sortKey="Stetzenbach, L D" sort="Stetzenbach, L D" uniqKey="Stetzenbach L" first="L. D." last="Stetzenbach">L. D. Stetzenbach</name>
</author>
</analytic>
<series>
<title level="j">Encyclopedia of Microbiology</title>
<imprint>
<date when="2009">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>Inhalation exposes the upper and lower respiratory tracts of humans to a variety of airborne particles and vapors. Airborne transmission of pathogenic microorganisms to humans from the environment, animals, or other humans can result in disease. Inhalation is an important route of exposure as the lung is more susceptible to infection than the gastrointestinal tract. Ingested microorganisms must past through the acidic environment of the stomach before they can colonize tissue while inhaled microorganisms are deposited directly on the moist surfaces of the respiratory tract. Inhalation of microbial aerosols can elicit adverse human health effects including infection, allergic reaction, inflammation, and respiratory disease. Following inhalation, infectious viruses, bacteria, and fungi can establish in host cells of the respiratory tract. Some are translocated and infect the gastrointestinal tract and other tissues. This chapter discusses human viral, bacterial, and fungal diseases transmitted via aerosols. Viral diseases presented are influenza, severe acute respiratory syndrome (SARS), Norwalk-like viruses (NLVs) and hantavirus disease, measles, and varicella. Bacterial diseases are Legionnaires’ disease, tuberculosis, and nontubercule mycobacterial disease. Exposure to some Gram-negative and Gram-positive bacteria, endotoxin, and actinomycetes when dispersed through the air can result in disease following inhalation. Fungal diseases included are histoplasmosis, coccidiomycosis, blastomycosis, cryptococcosis, and aspergillosis. The threat of bioterrorism with airborne infectious agents is also briefly presented.</p>
</div>
</front>
<back>
<div1 type="bibliography">
<listBibl>
<biblStruct>
<analytic>
<author>
<name sortKey="Cox, C S" uniqKey="Cox C">C.S. Cox</name>
</author>
<author>
<name sortKey="Wathes, C M" uniqKey="Wathes C">C.M. Wathes</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Dull, P M" uniqKey="Dull P">P.M. Dull</name>
</author>
<author>
<name sortKey="Wilson, K E" uniqKey="Wilson K">K.E. Wilson</name>
</author>
<author>
<name sortKey="Kournikakis, B" uniqKey="Kournikakis B">B. Kournikakis</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Fields, B S" uniqKey="Fields B">B.S. Fields</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Laitinen, S" uniqKey="Laitinen S">S. Laitinen</name>
</author>
<author>
<name sortKey="Kangas, J" uniqKey="Kangas J">J. Kangas</name>
</author>
<author>
<name sortKey="Husman, K" uniqKey="Husman K">K. Husman</name>
</author>
<author>
<name sortKey="Susitaival, P" uniqKey="Susitaival P">P. Susitaival</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Muder, R R" uniqKey="Muder R">R.R. Muder</name>
</author>
<author>
<name sortKey="Yu, V L" uniqKey="Yu V">V.L. Yu</name>
</author>
</analytic>
</biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<pmc article-type="chapter-article">
<pmc-dir>properties open_access</pmc-dir>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Encyclopedia of Microbiology</journal-id>
<journal-title-group>
<journal-title>Encyclopedia of Microbiology</journal-title>
</journal-title-group>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmc">7150350</article-id>
<article-id pub-id-type="publisher-id">B978-0-12-373944-5.00177-2</article-id>
<article-id pub-id-type="doi">10.1016/B978-012373944-5.00177-2</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Airborne Infectious Microorganisms</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="mc0005">
<name>
<surname>Stetzenbach</surname>
<given-names>L.D.</given-names>
</name>
</contrib>
</contrib-group>
<aff id="mc0415">University of Nevada, Las Vegas NV, USA</aff>
<contrib-group>
<contrib contrib-type="editor">
<name>
<surname>Schaechter</surname>
<given-names>Moselio</given-names>
</name>
</contrib>
</contrib-group>
<aff>San Diego State University, San Diego, CA, USA</aff>
<pub-date pub-type="pmc-release">
<day>17</day>
<month>2</month>
<year>2009</year>
</pub-date>
<pmc-comment> PMC Release delay is 0 months and 0 days and was based on .</pmc-comment>
<pub-date pub-type="ppub">
<year>2009</year>
</pub-date>
<pub-date pub-type="epub">
<day>17</day>
<month>2</month>
<year>2009</year>
</pub-date>
<fpage>175</fpage>
<lpage>182</lpage>
<permissions>
<copyright-statement>Copyright © 2009 Elsevier Inc. All rights reserved.</copyright-statement>
<copyright-year>2009</copyright-year>
<copyright-holder>Elsevier Inc.</copyright-holder>
<license>
<license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p>
</license>
</permissions>
<abstract>
<p>Inhalation exposes the upper and lower respiratory tracts of humans to a variety of airborne particles and vapors. Airborne transmission of pathogenic microorganisms to humans from the environment, animals, or other humans can result in disease. Inhalation is an important route of exposure as the lung is more susceptible to infection than the gastrointestinal tract. Ingested microorganisms must past through the acidic environment of the stomach before they can colonize tissue while inhaled microorganisms are deposited directly on the moist surfaces of the respiratory tract. Inhalation of microbial aerosols can elicit adverse human health effects including infection, allergic reaction, inflammation, and respiratory disease. Following inhalation, infectious viruses, bacteria, and fungi can establish in host cells of the respiratory tract. Some are translocated and infect the gastrointestinal tract and other tissues. This chapter discusses human viral, bacterial, and fungal diseases transmitted via aerosols. Viral diseases presented are influenza, severe acute respiratory syndrome (SARS), Norwalk-like viruses (NLVs) and hantavirus disease, measles, and varicella. Bacterial diseases are Legionnaires’ disease, tuberculosis, and nontubercule mycobacterial disease. Exposure to some Gram-negative and Gram-positive bacteria, endotoxin, and actinomycetes when dispersed through the air can result in disease following inhalation. Fungal diseases included are histoplasmosis, coccidiomycosis, blastomycosis, cryptococcosis, and aspergillosis. The threat of bioterrorism with airborne infectious agents is also briefly presented.</p>
</abstract>
<kwd-group>
<kwd>airborne infectious bacteria</kwd>
<kwd>airborne infectious fungi</kwd>
<kwd>airborne infectious viruses</kwd>
<kwd>aspergillosis</kwd>
<kwd>avian influenza</kwd>
<kwd>bioaerosol</kwd>
<kwd>bioterrorism</kwd>
<kwd>blastomycosis</kwd>
<kwd>coccidiomycosis</kwd>
<kwd>cryptococcosis</kwd>
<kwd>hantaviruses</kwd>
<kwd>histoplasmosis</kwd>
<kwd>infectious microorganisms</kwd>
<kwd>influenza</kwd>
<kwd>legionnaires’ disease</kwd>
<kwd>measles</kwd>
<kwd>
<italic>Nocardia</italic>
</kwd>
<kwd>Norwalk-like viruses</kwd>
<kwd>severe acute respiratory syndrome</kwd>
<kwd>smallpox</kwd>
<kwd>tuberculosis</kwd>
<kwd>varicella</kwd>
</kwd-group>
<kwd-group>
<kwd>HPS, Hantavirus pulmonary syndrome</kwd>
<kwd>HVAC, Heating, ventilation, and air conditioning</kwd>
<kwd>NLVs, Norwalk-like viruses</kwd>
<kwd>SARS, Severe acute respiratory syndrome</kwd>
<kwd>SARS-CoV, SARS-associated coronavirus</kwd>
<kwd>WMD, weapons of mass destruction</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s0005">
<title>Defining Statement</title>
<p id="p0005">Inhalation of airborne pathogenic microorganisms can elicit adverse human health effects including infection, allergic reaction, inflammation, and respiratory disease. This chapter discusses viruses, bacteria, endotoxin, and fungi that are dispersed through the air and can result in infection following inhalation.</p>
</sec>
<sec id="s0010">
<title>Introduction</title>
<p id="p0010">Inhalation exposes the upper and lower respiratory tracts of humans to a variety of airborne particles and vapors. Airborne transmission of pathogenic microorganisms to humans from the environment, animals, or other humans can result in disease. The lung is more susceptible to infection than the gastrointestinal tract as ingested microorganisms must past through the acidic environment of the stomach before they can colonize tissue, while inhaled microorganisms are deposited directly on the moist surfaces of the respiratory tract. Inhalation of microbial aerosols can elicit adverse human health effects including infection, allergic reaction, inflammation, and respiratory disease.</p>
</sec>
<sec id="s0015">
<title>Bioaerosols</title>
<p id="p0015">A bioaerosol is an airborne collection of biological material. Bioaerosols can be comprised of bacterial cells and cellular fragments, fungal spores and fungal hyphae, viruses, and by-products of microbial metabolism. Pollen grains and other biological material can also be airborne as a bioaerosol. Microbial aerosols are generated in outdoor and indoor environments as a result of a variety of natural and anthroprogenic activities. Wind, rain and wave splash, spray irrigation, wastewater treatment activity, cooling towers and air handling water spray systems, and agricultural processes such as harvesting and tilling are examples of activities that generate bioaerosols outdoors. Indoors bioaerosols are generated and dispersed mechanical and human activity. Industrial and manufacturing practices and biofermentation procedures can generate high concentrations of microbial aerosols. Heating, ventilation, and air conditioning (HVAC) systems, water spray devices (e.g., showerheads and humidifiers), and cleaning (e.g., dusting, sweeping, vacuuming, and mopping) result in the transport of microbial materials in the air. Talking and coughing generate bioaerosols from individuals, some of which may be infectious. Facilities with medical, dental, or animal care practices can generate infectious microbial aerosols.</p>
<p id="p0020">The individual particle size of particulate material in bioaerosols is generally 0.3–100 μm in diameter; larger particles tend to settle rapidly and are not readily transported in the air. Virus particles are nanometer in size, bacterial cells are approximately 1 μm in diameter, and fungal spores are  >1 μm. These microorganisms can be dispersed in the air as single units, but are often present as aggregate formations. The larger aggregates have different aerodynamic properties than single-cell units; therefore their dispersal may be different than single-unit particles. Aggregates of biological material also afford protection from environmental stresses such as desiccation, and exposure to ultraviolet radiation ozone and other pollutants in the atmosphere. Often bacterial cells and virus particles are associated with skin cells, dust, and other organic or inorganic material. During agricultural practices (e.g., during harvesting, and tilling), fungus spores are released from plant surfaces and the soil and raft on other particulate matter. This ‘rafting’ affects the aerodynamic characteristics and the survival of the cells in the bioaerosol. When biological material is dispersed from water sources (e.g., splash, rainfall, or cooling towers and fountains), it is generally surrounded by a thin layer of water. This moisture layer also changes the aerodynamic properties and aids in the survivability of the microorganisms while airborne.</p>
<p id="p0025">Airborne particulate will remain airborne until settling occurs or they are inhaled. Following inhalation, large airborne particles are lodged in the upper respiratory tract (i.e., nose and nasopharynx). Particles  <6 μm in diameter are transported to the lung where the 1–2 μm particles have the greatest retention in the alveoli. The average person inhales approximately 10 m
<sup>3</sup>
of air per day, which may result in an infective dose for some airborne pathogens. Diseases resulting from inhalation of bioaerosols include allergic reaction, irritation, inflammation, infection, and respiratory disease.</p>
<p id="p0030">The by-products of microbial metabolism and foreign proteins of microorganisms and fragments of cells can result in allergic reactions and irritant responses. The inflammatory response and allergic reactivity can be debilitating to sensitized individuals in indoor and outdoor environments, and it has been demonstrated following exposure to airborne bacterial fragments present in airborne dust. However, the greatest adverse health impact following exposure to airborne microorganisms is associated with inhalation of infectious agents. These infectious agents include viruses, bacteria, and fungi. The following sections introduce representative pathogens of each grouping that are associated with the airborne route of exposure.
<xref rid="t0005" ref-type="table">Table 1</xref>
provides a summary of the pathogens presented in this chapter.
<table-wrap position="float" id="t0005">
<label>Table 1</label>
<caption>
<p>Characteristics of selected infectious microorganisms transmitted via the airborne route of exposure</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Organism</th>
<th align="left" valign="top">Characteristics</th>
<th align="left" valign="top">Disease</th>
<th align="left" valign="top">Reservoir</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">
<italic>Aspergillus</italic>
spp.</td>
<td align="left" valign="top">Fungus, a mold with spherical spores ∼1 μm in diameter, variety of species including
<italic>A</italic>
.
<italic>fumigatus, A. flavus, A. nidulans, A. terrus</italic>
, and
<italic>A. niger</italic>
</td>
<td align="left" valign="top">Aspergillosis, aspergilloma (fungus ball), allergic sinusitis, and allergic bronchopulmonary disease</td>
<td align="left" valign="top">Environment, compost and plant, material, soil, dust, building materials</td>
</tr>
<tr>
<td align="left" valign="top">
<italic>Blastomyces dermatitidis</italic>
</td>
<td align="left" valign="top">Fungus; 8–15 μm spherical yeast cells</td>
<td align="left" valign="top">Flu-like illness, chronic lung disease</td>
<td align="left" valign="top">Moist soil enriched with decomposing organic debris</td>
</tr>
<tr>
<td align="left" valign="top">
<italic>Coccidioides immitis</italic>
</td>
<td align="left" valign="top">Fungus; 5 μm alternating barrel-shaped arthrospores</td>
<td align="left" valign="top">Coccidioidomycosis/San Joaquin Valley fever</td>
<td align="left" valign="top">Desert soils with intermittent wet and hot dry cycles</td>
</tr>
<tr>
<td align="left" valign="top">
<italic>Cryptococcus neoformans</italic>
</td>
<td align="left" valign="top">Fungus; vegetative form (yeast cell) 2.5–10 μm, basidiospores 1.8–3 μm</td>
<td align="left" valign="top">Cryptococcosis</td>
<td align="left" valign="top">Pigeon droppings debris and soil associated with birds</td>
</tr>
<tr>
<td align="left" valign="top">
<italic>Histoplasma capsulatum</italic>
</td>
<td align="left" valign="top">Fungus; dimorphic 2–5 μm oval cells</td>
<td align="left" valign="top">Flu-like symptoms, chronic lung disease, dissemination to other organ systems</td>
<td align="left" valign="top">Environment</td>
</tr>
<tr>
<td align="left" valign="top">Influenza A viruses</td>
<td align="left" valign="top">Virus; single-stranded RNA, three distinct types (i.e., A, B, and C), 80–120 nm</td>
<td align="left" valign="top">Influenza, pneumonia, acute respiratory distress</td>
<td align="left" valign="top">Human respiratory secretions; avian flu associated with birds</td>
</tr>
<tr>
<td align="left" valign="top">
<italic>Legionella pneumophila</italic>
</td>
<td align="left" valign="top">Bacterium; vegetative Gram-negative bacillus, 0.5–1 μm by 2 μm</td>
<td align="left" valign="top">Legionnaires’ disease and Pontiac fever</td>
<td align="left" valign="top">Ubiquitous in freshwater environments, an intercellular parasite of protozoa</td>
</tr>
<tr>
<td align="left" valign="top">Measles/Rubeola</td>
<td align="left" valign="top">Virus, enveloped, RNA, 100–250 nm</td>
<td align="left" valign="top">Acute, febrile disease with an exanthematous rash, dry cough, sore throat, headache</td>
<td align="left" valign="top">Human – only known reservoir</td>
</tr>
<tr>
<td align="left" valign="top">
<italic>Mycobacterium tuberculosis</italic>
</td>
<td align="left" valign="top">Bacterium; acid-fast, 0.2–0.6 μm by 1–10 μm</td>
<td align="left" valign="top">Tuberculosis</td>
<td align="left" valign="top">Infected persons</td>
</tr>
<tr>
<td align="left" valign="top">Norwalk-like virus</td>
<td align="left" valign="top">Virus; RNA, ∼30 nm, amorphous surface and ragged outline</td>
<td align="left" valign="top">Diarrhea, sudden projectile vomiting</td>
<td align="left" valign="top">Infected persons, surfaces</td>
</tr>
<tr>
<td align="left" valign="top">Severe acute respiratory syndrome – associated coronavirus</td>
<td align="left" valign="top">Virus; RNA with helical symmetry</td>
<td align="left" valign="top">Acute respiratory distress</td>
<td align="left" valign="top">Infected persons</td>
</tr>
<tr>
<td align="left" valign="top">Sin Nombre virus</td>
<td align="left" valign="top">Virus; single-stranded RNA hantavirus</td>
<td align="left" valign="top">Respiratory distress</td>
<td align="left" valign="top">Rodent urine, saliva, and feces especially
<italic>Peromyscus maniculatus</italic>
(deer mouse)</td>
</tr>
<tr>
<td align="left" valign="top">Varicella-zoster</td>
<td align="left" valign="top">Virus; double-stranded DNA, 150–200 nm</td>
<td align="left" valign="top">Chickenpox</td>
<td align="left" valign="top">Humans – only known reservoir; virus may be dormant until reactivates as shingles</td>
</tr>
</tbody>
</table>
</table-wrap>
</p>
</sec>
<sec id="s0020">
<title>Infectious Airborne Viruses</title>
<p id="p0035">Viruses are noncellular units consisting of either DNA or RNA, but not both. They do not have self-directed biosynthesis and, therefore, require a living host cell for replication. Following inhalation, infectious viruses can establish in host cells of the respiratory tract. Some are translocated and infect the gastrointestinal tract and other tissues.</p>
<sec id="s0025">
<title>Influenza</title>
<p id="p0040">Influenza is a contagious respiratory illness caused by flu viruses A, B, and C. There are subtypes of influenza type A viruses based on two proteins on the surface proteins of the virus, hemagglutinin (H) and neuraminidase (N). Many animals carry influenza A viruses, while influenza B viruses circulate among humans. Both influenza types A and B viruses cause epidemics of disease almost every winter. Influenza type C infections cause a mild respiratory illness and are not thought to cause epidemics. While symptoms can be mild, influenza may result in severe illness and death. The Centers for Disease Control and Prevention reports that there are more than 200 000 hospital admissions and 36 000 deaths per year in the United States due to influenza. All ages can have serious illness from influenza, but those more likely to have complications are people aged 65 years and older, people with chronic medical conditions, and very young children. Transmission of influenza viruses is from person to person in respiratory droplets expelled during coughing and sneezing. The droplets are propelled usually less than 3 ft through the air and deposited on people in close proximity. Fomites contaminated with settled infectious droplets can also serve as a vehicle for transmission of influenza.</p>
<p id="p0045">Avian influenza A viruses usually do not infect humans. However, cases of human infection with avian influenza viruses have been reported since 1997. Illness caused by several strains of avian influenza A viruses (e.g., H5N1, H7N2, H9N2, and H7N3) have been reported since 2004. The majority of human avian influenza infections have resulted from inhalation during direct contact with infected poultry or contaminated surfaces such as avian cages, or from the ingestion of uncooked blood of infected birds. Therefore, this influenza has been popularized as ‘bird flu’.</p>
<p id="p0050">The illnesses resulting from avian influenza infection in humans range from typical mild influenza-like symptoms (e.g., fever, sore throat, cough, and muscle aches) and conjunctivitis to more serious cases of pneumonia, acute respiratory distress, and other severe and life-threatening complications.</p>
<p id="p0055">To date, there have been no sustained human-to-human transmission of avian influenza A viruses, but because of the potential for these viruses to gain the ability to spread easily between people, monitoring for human infection and person-to-person transmission is important.</p>
</sec>
<sec id="s0030">
<title>Severe Acute Respiratory Syndrome</title>
<p id="p0060">Severe acute respiratory syndrome (SARS) is a newly reported respiratory illness. It was first reported in February 2003 in Asia. Since then, it has also been reported in North America and Europe. It is a viral respiratory illness caused by a coronavirus, termed SARS-associated coronavirus (SARS-CoV). Exposure to SARS-CoV results from close personal contact with infected individuals. Transmission is generally the result of touching the skin of an infected person or objects contaminated with infectious droplets and then transferring the virus to the new host’s eyes, nose, or mouth. Coughing or sneezing by an infected individual also releases droplets into the air that are propelled a short distance (<1 m) and deposited on the mucous membranes of the mouth, nose, or eyes of persons who are nearby. It is possible that SARS can be spread further through the air by very small particles, but investigations to date suggest that this type of spread is unusual. Hand hygiene, use of gown, gloves, and eye protection when in contact with an infected individual, and use of an appropriate respirator minimizes the spread of SARS.</p>
</sec>
<sec id="s0035">
<title>Norwalk-Like Viruses</title>
<p id="p0065">Norwalk-like viruses (NLVs) are a group of highly infectious viruses first reported following an outbreak of gastroenteritis in 1972. The infectious dose is estimated at 10
<sup>1</sup>
–10
<sup>2</sup>
particles. Outbreaks of gastrointestinal infection resulting from exposure to NLVs are characterized by diarrhea and sudden projectile vomiting. While transmission of NLVs is primarily associated with the fecal–oral route, it has been estimated that over 30 million virus particles can be liberated during vomiting. Therefore, airborne transmission within close contact is highly likely.</p>
</sec>
<sec id="s0040">
<title>Hantaviruses</title>
<p id="p0070">Hantavirus pulmonary syndrome (HPS) is a life-threatening disease caused by rodent-borne hantaviruses. It is characterized by severe pulmonary illness and a mortality rate of 30–40%. The Sin Nombre virus causes the majority of HPS cases in the United States, and
<italic>Peromyscus maniculatus</italic>
(the deer mouse) is its predominant reservoir. The virus found in the rodent urine, saliva, and feces becomes aerosolized as mist from urine and saliva or dust from feces. Inhalation is the most common route of infection. However, touching the mouth or nose after handling contaminated materials or being bitten by an infected rodent also result in infection. Hantavirus is not spread from person to person. Classic symptoms of disease include fever, fatigue, and muscle aches. Symptoms progress in 4–10 days to cough and shortness of breath.</p>
</sec>
<sec id="s0045">
<title>Measles</title>
<p id="p0075">The disease measles is contracted by inhalation of infectious droplets expelled as respiratory secretions by an infected individual. The measles virus is also known as rubeola and the only known reservoir is humans. All strains of this virus belong to a single antigenic type and immunity is long lasting following infection.</p>
<p id="p0080">Fever, malaise anorexia, and respiratory symptoms mimic other respiratory infections, but the appearance of Koplik’s spots precedes a rash on the face that proceeds down the body to the soles and palms. Severe complications may occur including a chronic degenerative neurologic disease that occurs many years after a measles infection.</p>
<p id="p0085">Measles is worldwide, but the success of vaccination programs in developed countries has limited the number of cases of childhood measles. However, there are still sporadic cases of measles in the United States as a result of immigration and travel of foreign visitors who spread the infection to unvaccinated or unprotected persons.</p>
</sec>
<sec id="s0050">
<title>Varicella</title>
<p id="p0090">Chickenpox is a highly contagious disease caused by the varicella-zoster virus. Chickenpox is usually a self-limited disease lasting 4–5 days with fever, malaise, and a generalized vesicular rash of blister-like lesions. The rash covers the body, but it is usually more concentrated on the face, scalp, and trunk. Serious complications including bacterial infections of skin lesions, pneumonia, cerebellar ataxia, and encephalitis may occur, but are rare. Disease is spread by aerosol dissemination of the virus during coughing and sneezing by an infected person or it may become airborne directly from the skin lesions. Incidence of chickenpox is highest among children 1–6 years of age, but the licensing of a vaccine in 1995 and vaccination requirements for daycare and school children greatly reduced the impact of this virus in the United States. Following varicella infection, the virus becomes latent in sensory nerve ganglia and may reactivate later in life resulting in shingles.</p>
</sec>
</sec>
<sec id="s0055">
<title>Infectious Airborne Bacteria</title>
<p id="p0095">Unlike viruses that require a host cell, bacteria can colonize and grow on a variety of surfaces and in liquids when physical and nutritional factors are suitable. Therefore, bacteria can be released into the air from a variety of natural and anthroprogenic environments. When infectious bacteria are released into the air, they can be readily transported via bioaerosols to susceptible individuals.</p>
<sec id="s0060">
<title>Legionella</title>
<p id="p0100">The first report of Legionnaires’ disease followed the outbreak of respiratory illness among American Legion conventioneers in Philadelphia in 1976. Currently an estimated 10 000–15 000 cases of Legionnaires’ disease are reported in the United States per year. The causative agent,
<italic>Legionella pneumophila</italic>
, is a vegetative Gram-negative bacterium that is ubiquitous in freshwater environments worldwide. It survives as an intercellular parasite of protozoa thereby resulting in protection for the bacterium while in the environment. Infective aerosols are generated from contaminated water spray devices such as showerheads, evaporative condensers, humidifiers, and fountains. Following the inhalation,
<italic>L. pneumophila</italic>
replicates in host macrophage resulting in severe pneumonia. While
<italic>L. pneumophila</italic>
accounts for the majority of disease cases caused by this genus, 19 other
<italic>Legionella</italic>
species are also human pathogens, often causing disease in immunosuppressed patients.
<italic>Legionella</italic>
bacteria that cannot replicate in the lung are cited as the cause of Pontiac fever, a mild flu-like syndrome. Often these organisms are released in aerosols from whirlpool tubs. Pontiac fever results in many more cases of illness, but fewer deaths; Legionnaire’s disease has a much higher mortality, but lower morbidity.</p>
<p id="p0105">No human-to-human transmission has been documented. For an outbreak of Legionnaires’ disease to occur, a series of events must happen. A reservoir of infectious bacteria must be present, the environmental conditions must be right for the concentration of organisms to increase, the organisms must be infectious and the infectious bacteria must be dispersed resulting in human exposure, organisms must be deposited in the appropriate site in the human host, and the host must be susceptible to infection by the
<italic>Legionella</italic>
.</p>
</sec>
<sec id="s0065">
<title>
<italic>Mycobacterium</italic>
Species</title>
<p id="p0110">
<italic>Mycobacterium tuberculosis</italic>
is recognized for its role as the causative agent of human tuberculosis. Infected individuals can spread pathogenic bacilli when coughing, talking, speaking, laughing, and sneezing. Overcrowding and low-socioeconomic status are often contributing factors to the spread of tuberculosis as individuals are in close association and hygiene conditions are usually poor. The confined spaces of airplane cabins have been implicated in transmissions to passengers and flight crew members. Infectious aerosols resulting from the operation of suctioning instruments during medical treatment, manipulation of tuberculosis ulcers, drainage of necrotic tissue, and exposure during autopsy have also been cited as causes of nosocomial
<italic>M. tuberculosis</italic>
infections.</p>
<p id="p0115">Also, nontuberculosis mycobacterial species can be transported via the air and result in disease. Respiratory infection in immunocompromised patients has been associated with members of the
<italic>Mycobacterium avium</italic>
complex.
<italic>Mycobacterium leprae</italic>
bacilli have been reported from the nose blow of an untreated person with lepromatous Hansen’s disease (leprosy), and
<italic>Mycobacterium terrae</italic>
isolated from a water-damaged building demonstrated inflammatory responses in mouse lung during laboratory experiments.</p>
</sec>
<sec id="s0070">
<title>Other Gram-Negative Bacteria</title>
<p id="p0120">
<italic>Escherichia coli, Pantoea</italic>
(
<italic>Enterobacter</italic>
)
<italic>agglomerans, Pseudomonas</italic>
spp., and
<italic>Acinetobacter</italic>
spp. commonly isolated in cow barns, pig houses, and poultry barns are among the airborne Gram-negative bacteria associated with animal facilities that can result in human disease. Disease-causing Gram-negative bacteria are also dispersed into the air from wastewater treatment plants, vegetable and herb processing, and recycling facilities. These organisms can cause a variety of health problems, especially to the young, elderly, and immunocompromised persons.</p>
</sec>
<sec id="s0075">
<title>Endotoxin</title>
<p id="p0125">Endotoxin is a lipopolysaccharide component of the Gram-negative bacteria cell and is released during active cellular growth and after cell lysis. While it is not an infectious particle, endotoxin is biologically active material derived from bacteria that can affect many human organ systems and disrupt humoral and cellular host mediation systems. Symptoms of exposure to airborne exposure include chest tightness, cough, shortness of breath, fever, and wheezing. Obstruction of airflow and exacerbation of asthma has been related to airborne endotoxin concentrations, and atopic and nonatopic asthma have been associated with endotoxin exposure because of its ability to induce inflammatory reactions. Repeated inhalation exposure has been shown to induce allergen-specific airway inflammation.</p>
<p id="p0130">Airborne endotoxin exposure is a concern in dusty occupational facilities such as cotton processing facilities and agricultural settings, and in industrial environments that utilize water spray components (e.g., machining fluids). Indoor airborne endotoxin is a concern with humidified mechanical air conditioning systems. The presence of dogs, moisture, and settled dust increase the likelihood of airborne endotoxin in the home.</p>
</sec>
<sec id="s0080">
<title>Gram-Positive Non-Spore-Forming Bacteria</title>
<p id="p0135">Numerous Gram-positive bacteria are commonly disseminated from the skin, oral and nasal surfaces, and hair of humans. Commonly
<italic>Staphylococcus</italic>
spp. are among the nonendospore-forming Gram-positive bacteria isolated in indoor air samples. The presence of these cells in the air increases the likelihood of nosocomial infections in healthcare settings. Nosocomial infections by airborne pathogens and with antibiotic-resistant bacteria in hospital environments are transmitted among patients through aerosol dispersal from patients, staff, surfaces, and aspiration from respiratory instrumentation. Airborne dispersal of pathogens is also a concern in home care and assisted living environments.</p>
<p id="p0140">Additionally, the Gram-positive actinomycetes have been associated with illness in occupants of water-damaged buildings. Often they are associated with fungi that colonize on surfaces and building materials following water intrusion.</p>
</sec>
</sec>
<sec id="s0085">
<title>Infectious Airborne Fungi</title>
<p id="p0145">Fungi are ubiquitous in nature. They utilize organic matter for their metabolism depending on the genus they can readily disperse spores, cellular fragments, or cells into the air. Infectious fungi can cause serious mycoses of the respiratory tract and some are disseminated to the bone and other systems in the body.</p>
<sec id="s0090">
<title>Histoplasma capsulatum</title>
<p id="p0150">Inhalation of spores of the fungus
<italic>Histoplasma capsulatum</italic>
can result in histoplasmosis. This disease is not transmitted from an infected person or animal to someone else but is the result of airborne transport from environmental surfaces. Histoplasmosis primarily affects a person’s lungs, and its symptoms vary greatly. Infected people are generally asymptomatic or they experience mild flu-like symptoms not requiring medical attention. Chronic lung disease resulting from infection with
<italic>H. capsulatum</italic>
resembles tuberculosis, and can worsen over months or years. The most severe and rarest form of histoplasmosis occurs when it is disseminated involving spreading outside the lungs. If untreated, disseminated histoplasmosis is fatal.</p>
<p id="p0155">
<italic>H. capsulatum</italic>
is a dimorphic fungus with a mold (mycelial phase) when it is growing in soil at ambient temperatures, and a yeast phase after being inhaled by humans or animals. The mold spores are either microconidia ranging from 2 to 5 μm in diameter or macroconidia ranging from 8 to 15 μm. The yeast cells of
<italic>H. capsulatum</italic>
are oval to round in shape with diameters ranging from 1 to 5 μm.</p>
</sec>
<sec id="s0095">
<title>Coccidioides immitis</title>
<p id="p0160">Inhalation of airborne
<italic>Coccidioides immitis</italic>
arthroconidia may result in the disease coccidioidomycosis (also called San Joaquin Valley fever). Within 48–72 h after inhalation and deposition in the lung, the arthroconidia change into spherules and develop numerous endospores. When spherules rupture, they release endospores which have the capacity to develop into a mature spherule.</p>
<p id="p0165">Approximately 40% of those who become infected are symptomatic with flu-like illness with fever, cough, headaches, rash, and myalgia. Some individuals fail to recover and suffer chronic pulmonary infection. Others will develop widespread disseminated infection that may affect the soft tissues, joints and bone, or meninges. Coccidioidomycosis meningitis may lead to permanent neurologic damage. The immunocompromised and HIV-infected persons suffer severe pulmonary conditions and diffuse lung disease.</p>
<p id="p0170">
<italic>C. immitis</italic>
grows in the soil of semiarid areas. It is primarily found in the Lower Sonoran life zone and is endemic in the south-western United States; it is also found in parts of Mexico and South America. Exposure to airborne arthrospores occurs after disturbance of contaminated soil by humans or natural disasters (e.g., dust storms and earthquakes). Persons in areas with endemic disease who have occupations exposing them to dust (e.g., construction or agricultural workers, and archeologists) are at risk. African-Americans and Asians, pregnant women during the third trimester, and immunocompromised persons have a higher risk than others.</p>
</sec>
<sec id="s0100">
<title>Blastomyces dermatitidis</title>
<p id="p0175">Blastomycosis is a symptomatic infection caused by the fungus
<italic>B. dermatitidis</italic>
. This fungus grows in moist soil that is enriched with decomposing organic debris, and it is endemic in parts of the southcentral, southeastern, and mid-western United States. It is also present in some areas of Central and South America and parts of Africa. Exposure is via the inhalation of airborne spores, generally after disturbance of contaminated soil. Generally, individuals who frequent wooded areas with endemic disease (e.g., farmers, forestry workers, hunters, and campers) are the most exposed ones.</p>
<p id="p0180">While there are only 1 or 2 cases per 100 000 population in areas with endemic disease, infection results in a flu-like illness with fever, chills, productive cough, myalgia, arthralgia, and pleuritic chest pain. However, some infected individuals fail to recover and develop chronic pulmonary infection and permanent lung damage. Other individuals develop widespread disseminated infection that may involve the skin, bones, and genitourinary tract, and occasionally the meninges of the brain are affected. The mortality rate for blastomycosis is approximately 5%.</p>
</sec>
<sec id="s0105">
<title>Cryptococcus neoformans</title>
<p id="p0185">
<italic>C. neoformans</italic>
var.
<italic>neoformans</italic>
causes most cryptococcal infections in humans. Infection with this yeast-like fungus can cause disease in apparently immunocompetent and immunocompromised persons, but most people do not get sick with cryptococcosis. Patients with T-cell deficiencies are the most susceptible to infection, and in the United States 85% of cases occur in HIV-infected persons. While the initial pulmonary infection is usually asymptomatic, cryptococcosis can cause serious symptoms of brain and spinal cord disease, such as headaches, dizziness, sleepiness, and confusion. Disseminated infection, especially meningoencephalitis, occurs in most patients.</p>
<p id="p0190">
<italic>C. neoformans</italic>
var.
<italic>neoformans</italic>
is found worldwide, and its habitat includes debris around pigeon roosts and soil contaminated with decaying pigeon or chicken droppings. Exposure generally occurs when dried bird droppings are disturbed and dust containing
<italic>Cryptococcus</italic>
disperses in the air. The exact nature of the infectious particles of
<italic>C. neoformans</italic>
is not known, but they are likely to be dehydrated yeast cells or basidiospores of the appropriate size range to be deposited in the lungs. Once in the lung, the yeast cells become rehydrated and acquire the characteristic polysaccharide capsule. Virulence of this organism is associated with the ability to produce the large capsule and shed great amounts of capsular material into the body fluids of the host.</p>
</sec>
<sec id="s0110">
<title>Aspergillus</title>
<p id="p0195">Aspergillosis is an invasive pulmonary infection with fever, cough, and chest pain. A localized pulmonary infection occurs for immunocompetent persons who have an underlying lung disease. The fungus infection may disseminate to other organs, including brain, skin, and bone. Exposure may also result in allergic sinusitis and allergic bronchopulmonary disease. A variety of
<italic>Aspergillus</italic>
species have been implicated.</p>
<p id="p0200">
<italic>Aspergillus fumigatus</italic>
and
<italic>Aspergillus flavus</italic>
most often have been cited, but
<italic>Aspergillus terreus, Aspergillus nidulans</italic>
, and
<italic>Aspergillus niger</italic>
have also been associated with the disease. These fungi are ubiquitous in the environment, and their conidia (spores) are disseminated from soil, compost piles and other decomposing plant matter, household dust, building materials, and ornamental plants. Water-damaged buildings can also be a source for exposure, and infections have been associated with dust exposure during building renovation or construction.</p>
</sec>
</sec>
<sec id="s0115">
<title>Airborne Bioterrorism</title>
<p id="p0205">The threat of purposeful transmission of airborne of pathogenic microbial and microbial toxins as weapons of mass destruction (WMD) has increased the awareness of the importance of bioaerosols. The Centers for Disease Control and Prevention and the Department of Health and Human Services have listed several pathogenic microorganisms as select agents. Of these,
<italic>Francisella tularensis, Yersinia pestis, Bacillus anthracis</italic>
, and Smallpox, the causative agents of tularemia, plague, anthrax, and smallpox, respectively, are ones that can be dispersed via aerosol and, therefore, are a concern for inhalation infection. Continued researches and awareness by public health professionals are needed to recognize these diseases and minimize the risk of exposure of the public.</p>
</sec>
<sec id="mc0419">
<title>See also:</title>
<p id="mc0211">Aeromicrobiology/Air Quality; Biological Warfare; Emerging Infections; Influenza; Respiratory Viruses; Smallpox, Historical; Surveillance of Infectious Diseases </p>
</sec>
<sec id="mc0420">
<title>Glossary</title>
<p id="mc0212">
<def-list>
<def-item>
<term id="g0005">aspergilloma</term>
<def>
<p id="mc0213">Pulmonary fungus ball consisting of a solid mass of hyphae growing in a lung cavity.</p>
</def>
</def-item>
<def-item>
<term id="g0010">aspergillosis</term>
<def>
<p id="mc0214">Disease caused by the inhalation of some species of the genus
<italic>Aspergillus</italic>
resulting in growth of the fungus in the lungs.</p>
</def>
</def-item>
<def-item>
<term id="g0015">bioaerosol</term>
<def>
<p id="mc0215">An airborne suspension of biological particles and microbial by-products.</p>
</def>
</def-item>
<def-item>
<term id="g0020">blastomycosis</term>
<def>
<p id="mc0216">A symptomatic infection caused by the inhalation of the fungus
<italic>Blastomyces dermatitidis</italic>
.</p>
</def>
</def-item>
<def-item>
<term id="g0025">chickenpox</term>
<def>
<p id="mc0217">Disease caused by the virus varicella-zoster.</p>
</def>
</def-item>
<def-item>
<term id="g0030">coccidioidomycosis</term>
<def>
<p id="mc0218">Disease caused by the inhalation of
<italic>Coccidioides immitis</italic>
arthroconidia (also called San Joaquin Valley fever).</p>
</def>
</def-item>
<def-item>
<term id="g0035">cryptococcosis</term>
<def>
<p id="mc0219">Disease caused by the fungus
<italic>Cryptococcus neoformans</italic>
.</p>
</def>
</def-item>
<def-item>
<term id="g0040">endotoxin</term>
<def>
<p id="mc0220">A lipopolysaccharide component of the Gram-negative bacteria cell released during active cellular growth and after cell lysis that can cause respiratory distress when inhaled.</p>
</def>
</def-item>
<def-item>
<term id="g0045">fomite</term>
<def>
<p id="mc0221">An inanimate object that transmits infectious agents to a new host.</p>
</def>
</def-item>
<def-item>
<term id="g0050">H5N1, H7N2, H9N2, and H7N3</term>
<def>
<p id="mc0222">Strains of avian influenza A viruses that have been linked to respiratory disease in humans.</p>
</def>
</def-item>
<def-item>
<term id="g0055">histoplasmosis</term>
<def>
<p id="mc0223">Disease caused by the infectious fungus
<italic>Histoplasma capsulatum</italic>
that can manifest as mild flu-like symptoms to chronic lung disease that resembles tuberculosis.</p>
</def>
</def-item>
<def-item>
<term id="g0060">HPS</term>
<def>
<p id="mc0224">Hantavirus pulmonary syndrome.</p>
</def>
</def-item>
<def-item>
<term id="g0065">Legionnaires’ disease</term>
<def>
<p id="mc0225">A severe respiratory disease resulting from the inhalation of
<italic>Legionella pneumophila</italic>
.</p>
</def>
</def-item>
<def-item>
<term id="g0070">measles</term>
<def>
<p id="mc0226">Term for the disease caused by the virus of the same name.</p>
</def>
</def-item>
<def-item>
<term id="g0075">Mycobacterium tuberculosis</term>
<def>
<p id="mc0227">The causative agent of human tuberculosis.</p>
</def>
</def-item>
<def-item>
<term id="g0080">NLVs</term>
<def>
<p id="mc0228">Norwalk-like viruses.</p>
</def>
</def-item>
<def-item>
<term id="g0085">Pontiac fever</term>
<def>
<p id="mc0229">A mild flu-like syndrome following inhalation of nonviable
<italic>Legionella pneumophila</italic>
.</p>
</def>
</def-item>
<def-item>
<term id="g0090">rubeola</term>
<def>
<p id="mc0230">Another name for the disease measles.</p>
</def>
</def-item>
<def-item>
<term id="g0095">SARS</term>
<def>
<p id="mc0231">Severe acute respiratory syndrome.</p>
</def>
</def-item>
<def-item>
<term id="g0100">SARS-CoV</term>
<def>
<p id="mc0232">Severe acute respiratory syndrome associated coronavirus.</p>
</def>
</def-item>
<def-item>
<term id="g0105">Sin Nombre virus</term>
<def>
<p id="mc0233">Causative agent of the majority of hantavirus pulmonary syndrome cases in the United States.</p>
</def>
</def-item>
</def-list>
</p>
</sec>
</body>
<back>
<ref-list id="mc0159">
<title>Further Reading</title>
<ref id="b0005">
<element-citation publication-type="book" id="mc0405">
<person-group person-group-type="author">
<name>
<surname>Cox</surname>
<given-names>C.S.</given-names>
</name>
<name>
<surname>Wathes</surname>
<given-names>C.M.</given-names>
</name>
</person-group>
<chapter-title>Bioaerosols in the environment</chapter-title>
<person-group person-group-type="editor">
<name>
<surname>Cox</surname>
<given-names>C.S.</given-names>
</name>
<name>
<surname>Wathes</surname>
<given-names>C.M.</given-names>
</name>
</person-group>
<source>Bioaerosols Handbook</source>
<year>1995</year>
<publisher-name>Lewis Publishers</publisher-name>
<publisher-loc>Boca Raton, FL</publisher-loc>
<fpage>11</fpage>
<lpage>14</lpage>
</element-citation>
</ref>
<ref id="b0010">
<element-citation publication-type="journal" id="mc0406">
<person-group person-group-type="author">
<name>
<surname>Dull</surname>
<given-names>P.M.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>K.E.</given-names>
</name>
<name>
<surname>Kournikakis</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>
<italic>Bacillus anthracis</italic>
aerosolization associated with a contaminated mail sorting machine</article-title>
<source>Emerging Infectious Diseases</source>
<volume>8</volume>
<year>2002</year>
<fpage>1044</fpage>
<lpage>1047</lpage>
<pub-id pub-id-type="pmid">12396913</pub-id>
</element-citation>
</ref>
<ref id="b0015">
<element-citation publication-type="book" id="mc0407">
<person-group person-group-type="author">
<name>
<surname>Fields</surname>
<given-names>B.S.</given-names>
</name>
</person-group>
<chapter-title>
<italic>Legionella</italic>
and legionnaires’ disease</chapter-title>
<person-group person-group-type="editor">
<name>
<surname>Hurst</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Crawford</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Garland</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Lipson</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Mills</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Stetzenbach</surname>
<given-names>L.D.</given-names>
</name>
</person-group>
<source>Manual of Environmental Microbiology</source>
<edition>3rd edn.</edition>
<year>2007</year>
<publisher-name>ASM Press</publisher-name>
<publisher-loc>Washington, DC</publisher-loc>
<fpage>1005</fpage>
<lpage>1015</lpage>
</element-citation>
</ref>
<ref id="b0020">
<element-citation publication-type="journal" id="mc0408">
<person-group person-group-type="author">
<name>
<surname>Laitinen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kangas</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Husman</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Susitaival</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Evaluation of exposure to airborne bacterial endotoxins and peptidoglycans in selected work environments</article-title>
<source>Annals of Agricultural and Environmental Medicine</source>
<volume>8</volume>
<year>2001</year>
<fpage>213</fpage>
<lpage>219</lpage>
<pub-id pub-id-type="pmid">11748879</pub-id>
</element-citation>
</ref>
<ref id="b0025">
<element-citation publication-type="journal" id="mc0409">
<person-group person-group-type="author">
<name>
<surname>Muder</surname>
<given-names>R.R.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>V.L.</given-names>
</name>
</person-group>
<article-title>Infection due to
<italic>Legionella</italic>
species other than
<italic>L. pneumophila</italic>
</article-title>
<source>Clinical Infectious Disease</source>
<volume>35</volume>
<year>2002</year>
<fpage>990</fpage>
<lpage>998</lpage>
</element-citation>
</ref>
</ref-list>
</back>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000962 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000962 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Pmc
   |étape=   Corpus
   |type=    RBID
   |clé=     PMC:7150350
   |texte=   Airborne Infectious Microorganisms
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i   -Sk "pubmed:NONE" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021